Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications.
about
Individual characteristics, area social participation, and primary non-concordance with medication: a multilevel analysisOptimal lipid modification: the rationale for combination therapyMotivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspective.So much to do, so little time: care for the socially disadvantaged and the 15-minute visitNational Background is Associated with Disparities in Initiation and Persistence to Statin Treatment in Subjects with Diabetes in Denmark.A literature review to investigate the link between psychosocial characteristics and treatment adherence in cancer patients.Approach to antihypertensive adherence: a feasibility study on the use of student health coaches for uninsured hypertensive adults.Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy.The impact of health literacy on cardiovascular disease.Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity.Navigating to health: Evaluation of a community health center patient navigation program.Cardiovascular health disparities: a systematic review of health care interventions.Illustrated medication instructions as a strategy to improve medication management among Latinos: a qualitative analysis.Adherence to medication regimens among low-income patients with multiple comorbid chronic conditions.Factors affecting therapeutic compliance: A review from the patient's perspective.Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention.Measuring the rate of therapeutic adherence among outpatients with T2DM in EgyptRacial differences in medication adherence: A cross-sectional study of Medicare enrollees.Racial disparities in lipid control in patients with diabetes.Using quantile regression to assess disparities in medication adherence.Cost implications of new evidence on prevention of cardiovascular disease.Liquid Medication Dosing Errors by Hispanic Parents: Role of Health Literacy and English Proficiency.Across US Hospitals, Black Patients Report Comparable Or Better Experiences Than White Patients.Adherence to antihypertensive treatment and its determinants among urban slum dwellers in Kolkata, India.Adherence to Medical Cannabis Among Licensed Patients in IsraelLittle change of modifiable risk factors 1 year after stroke: a pilot study.Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population.The barriers and facilitators people with diabetes from a nonEnglish speaking background experience when managing their medications: a qualitative study.An association study of 43 SNPs in 16 candidate genes with atorvastatin response.
P2860
Q25256854-1BCB2721-54CF-47C6-B1D2-E3237112DDD4Q28219266-EE1644FA-DEDD-464F-823B-56D7DB2CE812Q34449612-E5FF223B-BDD8-4A11-8B07-7BE2E7C98795Q34834185-14AA0F74-6492-4A59-8222-D3D6736BB41EQ35155256-D815B0D4-597E-41D5-A34D-0F18FA60F82CQ35569367-18B8250B-3A22-4D14-99AB-D621C2E5E8FBQ35850210-9BDEB3E4-BCBB-430A-AD06-552FDBEC9E71Q35901659-74A21FD7-F082-4C36-922B-2D9F25AA1EA1Q36013042-BF46EA10-9945-4A3A-B2B2-DC4D807EF859Q36064234-F9BCBCC1-225A-4ED1-8FC2-B7009E195A5EQ36486398-43D4DF7E-88F6-4045-A8B7-87488F9C6CAAQ36632231-C5AD7F0F-0FBD-4F1C-ADAD-479160C8EF57Q36702101-7539377F-B65A-483E-BD5C-46160ABB9298Q36709885-5798867B-9A5D-4E6D-B72F-53709CBF7607Q36822915-8851A85D-C24D-403E-A6B7-0E6265364754Q36957306-34F18C25-4686-496D-B8D9-A00FC19F071AQ37063292-FE20FD8F-359C-415C-81EF-A98EBD10A9EBQ37086603-A40EF21E-6D4C-4FAF-9399-7B085CB47BC4Q37154916-68D4312E-E6CE-4F80-B4F2-9CFE817879C4Q37184314-D0CF1F61-2EFA-4509-9DB9-D3EB46A40639Q37609391-A3C13BA2-E89A-496B-8873-D9C5A5F14570Q38800702-416B8E5F-58ED-483A-BE28-B991253E9599Q39509440-03203533-BEB9-4FB6-85F1-B1D5B70FA949Q40007615-60F9101E-2180-4EF7-93D4-C1EA6486EA24Q41009348-6873583D-E9DF-4CCD-A9F5-406710CB8806Q43034683-6882FE4D-E013-4549-87FB-1D2329DDC1ABQ44236913-A284D4F7-A20A-4964-B984-4AB0EAE0BA9BQ45400789-74714BB9-32B0-421A-A752-9A4AAD773CD1Q46653214-A4EE0DC8-AC21-4BD7-9847-9175830D8FDF
P2860
Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Race, ethnicity, and sociocult ...... th lipid-lowering medications.
@ast
Race, ethnicity, and sociocult ...... th lipid-lowering medications.
@en
type
label
Race, ethnicity, and sociocult ...... th lipid-lowering medications.
@ast
Race, ethnicity, and sociocult ...... th lipid-lowering medications.
@en
prefLabel
Race, ethnicity, and sociocult ...... th lipid-lowering medications.
@ast
Race, ethnicity, and sociocult ...... th lipid-lowering medications.
@en
P2093
P1433
P1476
Race, ethnicity, and sociocult ...... th lipid-lowering medications.
@en
P2093
David L Brown
Edward J Brown
Jessica White
Narendra C Bhalodkar
Robert C Kaplan
P304
P356
10.1016/J.YPMED.2004.04.041
P407
P577
2004-12-01T00:00:00Z